Literature DB >> 22083715

The Vsa shield of Mycoplasma pulmonis is antiphagocytic.

Brandon M Shaw1, Warren L Simmons, Kevin Dybvig.   

Abstract

The infection of mice with Mycoplasma pulmonis is a model for studying chronic mycoplasmal respiratory disease. Many in vivo and in vitro studies have used the organism to gain a better understanding of host-pathogen interactions in chronic respiratory infection. The organism's Vsa proteins contain an extensive tandem repeat region. The length of the tandem repeat unit varies from as few as 11 amino acids to as many as 19. The number of tandem repeats can be as high as 60. The number of repeats varies at a high frequency due to slipped-strand mispairing events that occur during DNA replication. When the number of repeats is high, e.g., 40, the mycoplasma is resistant to lysis by complement but does not form a robust biofilm. When the number of repeats is low, e.g., 5, the mycoplasma is killed by complement when the cells are dispersed but has the capacity to form a biofilm that resists complement. Here, we examine the role of the Vsa proteins in the avoidance of phagocytosis and find that cells producing a protein with many tandem repeats are relatively resistant to killing by macrophages. These results may be pertinent to understanding the functions of similar proteins that have extensive repeat regions in other microbes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083715      PMCID: PMC3264316          DOI: 10.1128/IAI.06009-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Phagocytosis of microbes: complexity in action.

Authors:  David M Underhill; Adrian Ozinsky
Journal:  Annu Rev Immunol       Date:  2001-12-07       Impact factor: 28.527

2.  A unique, bifunctional site-specific DNA recombinase from Mycoplasma pulmonis.

Authors:  Ramakrishnan Sitaraman; Amy M Denison; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

3.  Surface diversity in Mycoplasma agalactiae is driven by site-specific DNA inversions within the vpma multigene locus.

Authors:  Michelle D Glew; Marc Marenda; Renate Rosengarten; Christine Citti
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

4.  The complete genome sequence of the murine respiratory pathogen Mycoplasma pulmonis.

Authors:  I Chambaud; R Heilig; S Ferris; V Barbe; D Samson; F Galisson; I Moszer; K Dybvig; H Wróblewski; A Viari; E P Rocha; A Blanchard
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

5.  Variable lipoprotein genes of Mycoplasma agalactiae are activated in vivo by promoter addition via site-specific DNA inversions.

Authors:  Ravenna Flitman-Tene; Sigalit Mudahi-Orenstein; Sharon Levisohn; David Yogev
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

6.  Epitope mapping of immunogenic and adhesive structures in repetitive domains of Mycoplasma bovis variable surface lipoproteins.

Authors:  K Sachse; J H Helbig; I Lysnyansky; C Grajetzki; W Müller; E Jacobs; D Yogev
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

7.  Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis.

Authors:  J M Hickman-Davis; J R Lindsey; S Matalon
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  The complete sequence of the mucosal pathogen Ureaplasma urealyticum.

Authors:  J I Glass; E J Lefkowitz; J S Glass; C R Heiner; E Y Chen; G H Cassell
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

9.  Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences.

Authors:  K K Singh; X Zhang; A S Patibandla; P Chien; S Laal
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

10.  Mycoplasma biofilms ex vivo and in vivo.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2009-06       Impact factor: 2.742

View more
  7 in total

1.  CpG underrepresentation and the bacterial CpG-specific DNA methyltransferase M.MpeI.

Authors:  Marek Wojciechowski; Honorata Czapinska; Matthias Bochtler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

2.  Rhamnose biosynthesis in mycoplasmas requires precursor glycans larger than monosaccharide.

Authors:  David S Jordan; James M Daubenspeck; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2013-07-19       Impact factor: 3.501

3.  Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host.

Authors:  Rohini Chopra-Dewasthaly; Joachim Spergser; Martina Zimmermann; Christine Citti; Wolfgang Jechlinger; Renate Rosengarten
Journal:  PLoS Pathog       Date:  2017-09-28       Impact factor: 6.823

4.  EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.

Authors:  Brandon M Shaw; James M Daubenspeck; Warren L Simmons; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2012-11-28       Impact factor: 2.742

5.  Rhamnose Links Moonlighting Proteins to Membrane Phospholipid in Mycoplasmas.

Authors:  James M Daubenspeck; Runhua Liu; Kevin Dybvig
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

6.  Sheep Infection Trials with 'Phase-Locked' Vpma Expression Variants of Mycoplasma agalactiae-Towards Elucidating the Role of a Multigene Family Encoding Variable Surface Lipoproteins in Infection and Disease.

Authors:  Rohini Chopra-Dewasthaly; Andreas Dagn; Christian Lohinger; René Brunthaler; Martina Flöck; Munkhtsetseg Kargl; Shrilakshmi Hegde; Joachim Spergser; Renate Rosengarten
Journal:  Microorganisms       Date:  2022-04-14

7.  Upregulation of PD-L1 Expression by Prostaglandin E2 and the Enhancement of IFN-γ by Anti-PD-L1 Antibody Combined With a COX-2 Inhibitor in Mycoplasma bovis Infection.

Authors:  Shinya Goto; Satoru Konnai; Yuki Hirano; Junko Kohara; Tomohiro Okagawa; Naoya Maekawa; Yamato Sajiki; Kei Watari; Erina Minato; Atsuhi Kobayashi; Satoshi Gondaira; Hidetoshi Higuchi; Masateru Koiwa; Motoshi Tajima; Eiji Taguchi; Ryoko Uemura; Shinji Yamada; Mika K Kaneko; Yukinari Kato; Keiichi Yamamoto; Mikihiro Toda; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal:  Front Vet Sci       Date:  2020-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.